When the METABRIC breast cancer data set was classified into each of the five intrinsic subtypes (i.e., luminal-A, luminal-B, HER2-enriched, basal-like, and normal-like) using the research-based 50-gene prediction analysis of microarray (PAM50) classifier [44], SOX2 expression was found to be significantly higher in the luminal-B and HER2-enriched subtypes (Figure 4B, middle panel). The gene discussed is SOX2; the disease is breast carcinoma.